<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35572152</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Journal of health service psychology</Title><ISOAbbreviation>J Health Serv Psychol</ISOAbbreviation></Journal><ArticleTitle>Assessment and Management of Long COVID.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>30</EndPage><MedlinePgn>21-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s42843-022-00055-8</ELocationID><Abstract><AbstractText>Almost two years into the pandemic, the scientific and healthcare communities continue to learn a great deal regarding COVID-19, the disease produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Broad variability during acute COVID-19 infection is seen, ranging from asymptomatic presentation to death. The vast majority of individuals who develop COVID-19 return to their pre-COVID-19 baseline within several weeks. However, a portion of patients will develop a post-COVID-19 syndrome of persistent cognitive, somatic, and behavioral symptoms. This syndrome, designated as post-acute sequelae of SARS-CoV-2 infection, is more commonly known as long COVID. The objectives of this paper are to inform psychologists regarding our current understanding of the underlying pathophysiology of COVID-19, review criteria for range of severity during acute illness, present clinical manifestations of long haul phenomena, and discuss the emerging literature base of evidence-based treatment and management approaches.</AbstractText><CopyrightInformation>&#xa9; National Register of Health Service Psychologists 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rivas-Vazquez</LastName><ForeName>Rafael A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Miami, FL USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rey</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Miami, FL USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Miami, FL USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivas-Vazquez</LastName><ForeName>Ana A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Miami, FL USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Health Serv Psychol</MedlineTA><NlmUniqueID>101759262</NlmUniqueID><ISSNLinking>2662-2645</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Health Serv Psychol. 2022;48(3):141. doi: 10.1007/s42843-022-00064-7</RefSource><PMID Version="1">35729924</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long haulers</Keyword><Keyword MajorTopicYN="N">PASC</Keyword></KeywordList><CoiStatement>Conflicts of interestWe have no known conflicts of interest, external funding, or other disclosures to make.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>4</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35572152</ArticleId><ArticleId IdType="pmc">PMC9086152</ArticleId><ArticleId IdType="doi">10.1007/s42843-022-00055-8</ArticleId><ArticleId IdType="pii">55</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Auwaerter, P. G. (2021). Coronavirus COVID-19 (SARS-COV-2): Johns Hopkins Abx Guide. Coronavirus COVID-19 (SARS-CoV-2) Johns Hopkins ABX Guide. Accessed November 17, 2021. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_.</Citation></Reference><Reference><Citation>Berk M, Williams LJ, Jacka FN, O&#x2019;Neil A, Pasco JA, Moylan S, et al. So depression is an inflammatory disease, but where does the inflammation come from? Current Controversies in Psychiatry. 2013;11:200. doi: 10.1186/1741-7015-11-200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-200</ArticleId><ArticleId IdType="pmc">PMC3846682</ArticleId><ArticleId IdType="pubmed">24228900</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini, M., Canoll, P. D., &amp; Klein, R. S. (2021). How COVID-19 Affects the Brain. JAMA Psychiatry. 10.1001/jamapsychiatry.2021.0500</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulware LE. Race disparities in the COVID-19 pandemic&#x2014;solutions lie in policy, not biology. JAMA Netw Open. 2020;3(8):e2018696. doi: 10.1001/jamanetworkopen.2020.18039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.18039</ArticleId><ArticleId IdType="pubmed">32809027</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuron L, Miller AH. Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacology &amp; Therapeutics. 2011;130(2):226&#x2013;238. doi: 10.1016/j.pharmthera.2011.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2011.01.014</ArticleId><ArticleId IdType="pmc">PMC3072299</ArticleId><ArticleId IdType="pubmed">21334376</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. (2020). Persistent symptoms in patients after acute COVID-19. JAMA. 11;324(6):603-605. doi: 10.1001/jama.2020.12603. PMID: 32644129; PMCID: PMC7349096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochemical and Biophysical Research Communications. 2020;525(1):135&#x2013;140. doi: 10.1016/j.bbrc.2020.02.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.02.071</ArticleId><ArticleId IdType="pmc">PMC7092824</ArticleId><ArticleId IdType="pubmed">32081428</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins, F.S. (2021). NIH launches new initiative to study &#x201c;Long COVID.&#x201d; National Institutes of Health (NIH). https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid.</Citation></Reference><Reference><Citation>Cothran TP, Kellman S, Singh S, Beck JS, Powell KJ, Bolton CJ, Tam JW. A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19. Brain, Behavior, and Immunity. 2020;88:957&#x2013;958. doi: 10.1016/j.bbi.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7309913</ArticleId><ArticleId IdType="pubmed">32590055</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The long haul. Science. 2020;369(6504):614&#x2013;617. doi: 10.1126/science.369.6504.614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.369.6504.614</ArticleId><ArticleId IdType="pubmed">32764050</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel. (2021). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed 5/13/2021</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. British Medical Journal. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, de Truchis P. Post&#x2013;COVID-19 chronic symptoms: a postinfectious entity? Clinical Microbiology and Infection. 2020;26(11):1448&#x2013;1449. doi: 10.1016/j.cmi.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re&#x2019;em, Y., &#x2026; Akrami, A. (2020). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. 10.1101/2020.12.24.20248802</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Galetta S. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021;96(4):e575&#x2013;e586. doi: 10.1212/wnl.0000000000010979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000010979</ArticleId><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a, L. F. (2020). Immune response, inflammation, and the clinical spectrum of COVID-19. Frontiers in Immunology, 11. 10.3389/fimmu.2020.01441</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308593</ArticleId><ArticleId IdType="pubmed">32612615</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner, P. (2020). For 7 weeks I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion. British Medical Journal Opinion. https://blogs.bmj.com/bmj/2020/05/05/paul-garner-people-who-have-a-more-protracted-illness-need-help-to-understand-and-cope-with-the-constantly-shifting-bizarre-symptoms/</Citation></Reference><Reference><Citation>G&#xf3;mez-Mesa JE, Galindo-Coral S, Montes MC, Mu&#xf1;oz Martin AJ. Thrombosis and coagulopathy in COVID-19. Current Problems in Cardiology. 2021;46(3):100742. doi: 10.1016/j.cpcardiol.2020.100742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100742</ArticleId><ArticleId IdType="pmc">PMC7605852</ArticleId><ArticleId IdType="pubmed">33243440</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Annals of Clinical and Translational Neurology. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is there an association between COVID-19 mortality and the renin-angiotensin system? A call for epidemiologic investigations. Clinical Infectious Diseases. 2020;71(15):870&#x2013;874. doi: 10.1093/cid/ciaa329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa329</ArticleId><ArticleId IdType="pmc">PMC7184340</ArticleId><ArticleId IdType="pubmed">32215613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel, N., Sanchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.S., Neuraz, A., &#x2026;Limosin, F. (2021). Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Molecular Psychiatry.10.1038/s41380-021-01021-4</Citation><ArticleIdList><ArticleId IdType="pubmed">33536545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, Meyer PT. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144(4):1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Y., Pinto, M.D., Borelli, J.L. Mehrabadi, M.A., Abrihim, H., Dutt, N., &#x2026; Downs, C.A. (2021b). COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: Looking for clarity in the haze of the pandemic. medRxiv 2021.03.03.21252086; doi: 10.1101/2021.03.03.21252086</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020;106(15):1127&#x2013;1131. doi: 10.1136/heartjnl-2020-317186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317186</ArticleId><ArticleId IdType="pubmed">32499236</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK. The Importance of Delirium and Delirium Prevention in Older Adults During Lockdowns. JAMA. 2021;325(17):1779. doi: 10.1001/jama.2021.2211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2211</ArticleId><ArticleId IdType="pmc">PMC8224815</ArticleId><ArticleId IdType="pubmed">33720288</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff, A. (2020, October 15). The tragedy of long COVID. Harvard Health. https://www.health.harvard.edu/blog/the-tragedy-of-the-post-covid-long-haulers-202010152479</Citation></Reference><Reference><Citation>Kotfis, K., Williams Roberson, S., Wilson, J. E., Dabrowski, W., Pun, B. T., &amp; Ely, E. W. (2020). COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Critical Care, 24(1). 10.1186/s13054-020-02882-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186945</ArticleId><ArticleId IdType="pubmed">32345343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, G. K. (2011). Hypoxia. 3. Hypoxia and neurotransmitter synthesis. American Journal of Physiology-Cell Physiology, 300(4). 10.1152/ajpcell.00019.2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3074630</ArticleId><ArticleId IdType="pubmed">21270298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert, N., El-Azab, S. A., Ramrakhiani, N. S., Barisano, A., Yu, L., &#x2026; Pinto, M. D. (2021). COVID-19 survivors&#x2019; reports of the timing, duration, and health impacts of post-acute sequelae of SARS-COV-2 (PASC) infection. 10.1101/2021.03.22.21254026</Citation></Reference><Reference><Citation>Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood &amp; cognitive impairment. Brain, Behavior, &amp; Immunity - Health. 2021;17:100347. doi: 10.1016/j.bbih.2021.100347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100347</ArticleId><ArticleId IdType="pmc">PMC8437695</ArticleId><ArticleId IdType="pubmed">34549199</ArticleId></ArticleIdList></Reference><Reference><Citation>Leentjens, J., van Haaps, T. F., Wessels, P. F., Schutgens, R. E., &amp; Middeldorp, S. (2021). COVID-19-associated coagulopathy and antithrombotic agents&#x2014;lessons after 1 year. The Lancet Haematology. 10.1016/s2352-3026(21)00105-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078884</ArticleId><ArticleId IdType="pubmed">33930350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19. JAMA. 2020;324(22):2292&#x2013;2300. doi: 10.1001/jama.2020.22760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22760</ArticleId><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez L, Hart LH, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA. 2021;325(8):719&#x2013;720. doi: 10.1001/jama.2020.26443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26443</ArticleId><ArticleId IdType="pubmed">33480972</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Song C, Lin A, Bonaccorso S, Kenis G, Jongh R, et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon- and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 1999;40(4):370&#x2013;379. doi: 10.1016/S0893-133X(98)00088-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0893-133X(98)00088-8</ArticleId><ArticleId IdType="pubmed">10088138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza, M.G., Zanardi, R., Palladini, M., Rovere-Querini, P., &amp; Benedetti, F. (2021). Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. 10.1016/j.euroneuro.2021.09.009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500775</ArticleId><ArticleId IdType="pubmed">34634679</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Divani AA. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Current Neurology and Neuroscience Reports. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine, Z.S., Phillips, N.A., B&#xe9;dirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J.L., Chertkow H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatric Society, 53: 695&#x2013;9. doi:10.1111/j.1532-5415.2005.53221.x. PMID 15817019</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard, L. (2021). SARS-CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiological Reports, 9(3). 10.14814/phy2.14726</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson, B.K., Francisco, E.B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., &#x2026; Mora, J. (2021a). Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. bioRxiv.06.25.449905; doi: 10.1101/2021.06.25.449905</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Frontiers in Immunology. 2021;12:2520. doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitharouli MC, Hagenaars SP, Glanville KP, Coleman JRI, Hotopf M, Lewis CM, Pariante CM. Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK biobank. American Journal of Psychiatry. 2021;178(6):522&#x2013;529. doi: 10.1176/appi.ajp.2020.20060947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2020.20060947</ArticleId><ArticleId IdType="pubmed">33985349</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Nagel E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiology. 2020;5(11):1265. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenberg A, Yirmiya R, Schuld A, Kruas T, Haack M, Morag A, Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry. 2001;58:445&#x2013;452. doi: 10.1001/archpsyc.58.5.445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.58.5.445</ArticleId><ArticleId IdType="pubmed">11343523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rink C, Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiological Genomics. 2011;43(10):521&#x2013;528. doi: 10.1152/physiolgenomics.00158.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00158.2010</ArticleId><ArticleId IdType="pmc">PMC3110894</ArticleId><ArticleId IdType="pubmed">20841499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c;long haulers&#x201d; stump experts. JAMA. 2020;324(14):1381. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt C. COVID-19 long haulers. Nature Biotechnology. 2021;39:908&#x2013;913. doi: 10.1038/s41587-021-00984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-00984-7</ArticleId><ArticleId IdType="pmc">PMC8277229</ArticleId><ArticleId IdType="pubmed">34257426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., &amp; Wen, C. (2020). Cytokine storm in COVID-19: The current evidence and treatment strategies. Frontiers in Immunology, 11. 10.3389/fimmu.2020.01708</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021;8(5):416&#x2013;427. doi: 10.1016/s2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology. 2020;20(6):363&#x2013;374. doi: 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., &#x2026; Wu, M. J. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March&#x2013;June 2020. MMWR. Morbidity and Mortality Weekly Report, 69(30), 993&#x2013;998. 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain&#x2013;Barr&#xe9; Syndrome associated with SARS-CoV-2. New England Journal of Medicine. 2020;382(26):2574&#x2013;2576. doi: 10.1056/nejmc2009191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NW, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry. 2020;7(10):875&#x2013;882. doi: 10.1016/s2215-0366(20)30287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(20)30287-x</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese A. Could Cognitive Behavioural Therapy Be an Effective Treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure study for Q-Fever fatigue syndrome. Healthcare (Basel, Switzerland) 2020;8(4):552. doi: 10.3390/healthcare8040552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8040552</ArticleId><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2021a, August 20). WHO coronavirus (COVID-19) dashboard with vaccination data.http://covid19.who.int</Citation></Reference><Reference><Citation>World Health Organization (2021b, October 6). A clinical case definition of post-COVI-19 condition by a Delphi consensus.https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Yehia BR, Winegar A, Fogel R, Fakih M, Ottenbacher A, Jesser C, et al. Association of race with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at 92 US hospitals. JAMA Netw Open. 2020;3(8):e2018039. doi: 10.1001/jamanetworkopen.2020.18039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.18039</ArticleId><ArticleId IdType="pmc">PMC7435340</ArticleId><ArticleId IdType="pubmed">32809033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical Immunology. 2020;215:108427. doi: 10.1016/j.clim.2020.108427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108427</ArticleId><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>